Meag Munich Ergo’s Accenture ACN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$4.74M Buy
15,865
+14,991
+1,715% +$4.57M 0.13% 93
2025
Q1
$273K Sell
874
-3,492
-80% -$1.23M 0.01% 154
2024
Q4
$1.54M Buy
4,366
+3,492
+400% +$1.26M 0.05% 125
2024
Q3
$309K Hold
874
0.01% 152
2024
Q2
$265K Sell
874
-19,795
-96% -$6.06M 0.01% 142
2024
Q1
$7.16M Sell
20,669
-2,249
-10% -$820K 0.26% 68
2023
Q4
$8.04M Sell
22,918
-114
-0.5% -$36.8K 0.31% 65
2023
Q3
$7.07M Buy
23,032
+77
+0.3% +$24.3K 0.31% 70
2023
Q2
$7.08M Sell
22,955
-3,111
-12% -$904K 0.31% 77
2023
Q1
$7.45M Sell
26,066
-9,781
-27% -$2.67M 0.35% 70
2022
Q4
$9.57M Buy
35,847
+1,101
+3% +$305K 0.51% 46
2022
Q3
$8.94M Buy
34,746
+65
+0.2% +$18.8K 0.54% 42
2022
Q2
$9.63M Buy
34,681
+25,312
+270% +$7.61M 0.57% 39
2022
Q1
$3.2M Buy
9,369
+7,930
+551% +$2.67M 0.23% 83
2021
Q4
$598K Hold
1,439
0.04% 130
2021
Q3
$460K Sell
1,439
-17,511
-92% -$5.7M 0.08% 144
2021
Q2
$5.59M Sell
18,950
-5,966
-24% -$1.71M 0.54% 65
2021
Q1
$6.88M Buy
24,916
+11,654
+88% +$3.01M 0.69% 30
2020
Q4
$3.42M Buy
13,262
+477
+4% +$114K 0.78% 29
2020
Q3
$2.89M Sell
12,785
-1,973
-13% -$452K 0.54% 44
2020
Q2
$3.17M Buy
14,758
+4,747
+47% +$898K 0.59% 39
2020
Q1
$1.63M Sell
10,011
-9,788
-49% -$1.89M 0.39% 73
2019
Q4
$4.17M Sell
19,799
-32,539
-62% -$6.34M 0.45% 57
2019
Q3
$9.97M Buy
52,338
+16,432
+46% +$3.18M 0.51% 46
2019
Q2
$6.58M Buy
35,906
+300
+0.8% +$53.9K 0.52% 45
2019
Q1
$6.23M Buy
35,606
+18,333
+106% +$2.88M 0.51% 46
2018
Q4
$2.43M Buy
17,273
+1,271
+8% +$201K 0.3% 92
2018
Q3
$2.71M Sell
16,002
-368
-2% -$61.3K 0.16% 174
2018
Q2
$2.72M Sell
16,370
-15,485
-49% -$2.41M 0.17% 177
2018
Q1
$4.68M Sell
31,855
-70,295
-69% -$11.1M 0.19% 165
2017
Q4
$15.8M Buy
+102,150
New +$14.8M 0.61% 38
2017
Q2
Sell
-182,783
Closed -$21.9M 283
2017
Q1
$21.9M Buy
182,783
+90,997
+99% +$10.9M 0.87% 18
2016
Q4
$10.8M Buy
+91,786
New +$10.9M 0.5% 64
2016
Q3
Sell
-171,862
Closed -$19.4M 257
2016
Q2
$19.4M Buy
+171,862
New +$19.9M 1.76% 14
2015
Q4
Sell
-221,606
Closed -$21.7M 238
2015
Q3
$21.7M Buy
221,606
+63,228
+40% +$6.27M 1.16% 15
2015
Q2
$15.4M Sell
158,378
-40,897
-21% -$3.91M 0.79% 36
2015
Q1
$18.8M Hold
199,275
0.9% 28
2014
Q4
$18M Buy
199,275
+118,578
+147% +$9.85M 0.81% 35
2014
Q3
$6.58M Buy
+80,697
New +$6.47M 0.3% 112
2014
Q1
Sell
-5,735
Closed -$469K 195
2013
Q4
$469K Buy
+5,735
New +$434K 0.03% 195

Other funds holding ACN

Meag Munich Ergo's ACN Position: Q2 2025 in Review

Meag Munich Ergo increased its Accenture (ACN) stake by 1,715% in Q2 2025, buying an estimated $4.57M and bringing the position to 15,865 shares worth $4.74M. The position accounts for 0.13% of the portfolio, ranked #93.

Meag Munich Ergo first reported a position in ACN in Q4 2013 and has held it in 40 quarters since. The position peaked at $21.9M in Q1 2017. 2,370 funds tracked by Wall St. Rank hold ACN as of Q2 2025.

  • Meag Munich Ergo held 15,865 shares of Accenture worth $4.74M as of Q2 2025.
  • Meag Munich Ergo bought 14,991 Accenture shares in Q2 2025, an estimated $4.57M.
  • Accenture made up 0.13% of Meag Munich Ergo's portfolio in Q2 2025, its #93 holding.
  • Meag Munich Ergo first reported a position in Accenture in Q4 2013 and has held it in 40 quarters since.
  • Meag Munich Ergo's Accenture position peaked at $21.9M in Q1 2017.
  • 2,370 funds tracked by Wall St. Rank held Accenture as of Q2 2025.

Based on Meag Munich Ergo's 13F filing for Q2 2025, filed 16 Jul 2025.